Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1985-11-27
pubmed:abstractText
Factor VIII antigen (VIII:CAg) exhibits molecular weight heterogeneity in normal plasma. We have compared the relative quantities of VIII:CAg forms present in normal individuals (n = 22) with VIII:CAg forms in renal dysfunction patients (n = 19) and in patients with disseminated intravascular coagulation (DIC; n = 7). In normal plasma, the predominant VIII: CAg form, detectable by sodium dodecyl sulfate polyacrylamide gel electrophoresis, was of molecular weight 2.4 X 10(5), with minor forms ranging from 8 X 10(4) to 2.6 X 10(5) D. A high proportion of VIII:CAg in renal dysfunction patients, in contrast, was of 1 X 10(5) mol wt. The patients' high 1 X 10(5) mol wt VIII: CAg level correlated with increased concentrations of serum creatinine, F1+2 (a polypeptide released upon prothrombin activation), and with von Willebrand factor. Despite the high proportion of the 1 X 10(5) mol wt VIII:CAg form, which suggests VIII:CAg proteolysis, the ratio of Factor VIII coagulant activity to total VIII:CAg concentration was normal in renal dysfunction patients. These results could be simulated in vitro by thrombin treatment of normal plasma, which yielded similar VIII:CAg gel patterns and Factor VIII coagulant activity to antigen ratios. DIC patients with high F1+2 levels but no evidence of renal dysfunction had an VIII:CAg gel pattern distinct from renal dysfunction patients. DIC patients had elevated concentrations of both the 1 X 10(5) and 8 X 10(4) mol wt VIII:CAg forms. We conclude that an increase in a particular VIII:CAg form correlates with the severity of renal dysfunction. The antigen abnormality may be the result of VIII:CAg proteolysis by a thrombinlike enzyme and/or prolonged retention of proteolyzed VIII:CAg fragments.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-13045017, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-13973081, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-304366, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-311586, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-4114358, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6401193, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6414554, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6418425, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6421875, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6432074, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6438527, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6438528, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6592007, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6776402, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6779877, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-6795628, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-7074214, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-7356933, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-7356959, http://linkedlifedata.com/resource/pubmed/commentcorrection/3932466-762106
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1406-11
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.